A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Clinical trial NCT07175038 · RECRUITING

Trial details

NCT number: NCT07175038
Sponsor: AllRock Bio, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension (PAH)Pulmonary Hypertension, Interstitial Lung Disease

Start date: 2025-10-01
Primary completion: 2027-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.